<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lee LA</submitter><funding>NIDCD NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>Horizon 2020</funding><funding>National Institutes of Health</funding><funding>European Commission</funding><funding>NIGMS NIH HHS</funding><pagination>104631</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10141508</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>299(5)</volume><pubmed_abstract>For decades, sarcomeric myosin heavy chain proteins were assumed to be restricted to striated muscle where they function as molecular motors that contract muscle. However, MYH7b, an evolutionarily ancient member of this myosin family, has been detected in mammalian nonmuscle tissues, and mutations in MYH7b are linked to hereditary hearing loss in compound heterozygous patients. These mutations are the first associated with hearing loss rather than a muscle pathology, and because there are no homologous mutations in other myosin isoforms, their functional effects were unknown. We generated recombinant human MYH7b harboring the D515N or R1651Q hearing loss-associated mutation and studied their effects on motor activity and structural and assembly properties, respectively. The D515N mutation </pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>Distinct effects of two hearing loss-associated mutations in the sarcomeric myosin MYH7b.</pubmed_title><pmcid>PMC10141508</pmcid><funding_grant_id>F31DC017927</funding_grant_id><funding_grant_id>F32 HL152543</funding_grant_id><funding_grant_id>777204</funding_grant_id><funding_grant_id>R01 HL141086</funding_grant_id><funding_grant_id>F31 DC017927</funding_grant_id><funding_grant_id>R01HL141086</funding_grant_id><funding_grant_id>R01 GM029090</funding_grant_id><funding_grant_id>R01GM029090</funding_grant_id><pubmed_authors>Buvoli AE</pubmed_authors><pubmed_authors>Lee LA</pubmed_authors><pubmed_authors>Stump WT</pubmed_authors><pubmed_authors>Geeves M</pubmed_authors><pubmed_authors>Greenberg MJ</pubmed_authors><pubmed_authors>Barrick SK</pubmed_authors><pubmed_authors>Walklate J</pubmed_authors><pubmed_authors>Leinwand LA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Distinct effects of two hearing loss-associated mutations in the sarcomeric myosin MYH7b.</name><description>For decades, sarcomeric myosin heavy chain proteins were assumed to be restricted to striated muscle where they function as molecular motors that contract muscle. However, MYH7b, an evolutionarily ancient member of this myosin family, has been detected in mammalian nonmuscle tissues, and mutations in MYH7b are linked to hereditary hearing loss in compound heterozygous patients. These mutations are the first associated with hearing loss rather than a muscle pathology, and because there are no homologous mutations in other myosin isoforms, their functional effects were unknown. We generated recombinant human MYH7b harboring the D515N or R1651Q hearing loss-associated mutation and studied their effects on motor activity and structural and assembly properties, respectively. The D515N mutation </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-04-30T12:29:53.565Z</modification><creation>2025-04-04T20:51:11.824Z</creation></dates><accession>S-EPMC10141508</accession><cross_references><pubmed>36963494</pubmed><doi>10.1016/j.jbc.2023.104631</doi></cross_references></HashMap>